Dr Carlo Palmieri

Publications


Journals

  • Palmieri C; Jones A. (4 Feb 2012). The 2011 EBCTCG polychemotherapy overview. Lancet. 379:390-392. DOI.
  • Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; et alRhim JS; Palmieri C; Cobb JP; Waxman J; Sturge J. (10 Nov 2011). TGFβ(1) -Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis. J Pathol. DOI.
  • Saini KS; Taylor C; Ramirez AJ; Palmieri C; Gunnarsson U; Schmoll HJ; Dolci SM; Ghenne C; et alMetzger-Filho O; Skrzypski M; Paesmans M; Ameye L; Piccart-Gebhart MJ; de Azambuja E. (2011). Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol. Aug 4. [Epub ahead of print].
  • Shaw JA; Page K; Blighe K; Hava N; Guttery D; Ward B; Brown J; Ruangpratheep C; et alStebbing J; Payne R; Palmieri C; Cleator S; Walker RA. (2011). Genomic analysis of circulating cell free DNA infers breast cancer dormancy. Genome Res. Oct 11. [Epub ahead of print].
  • Krell J; Januszewski A; Yan K; Palmieri C. (2011). Role of fulvestrant in the management of postmenopausal breast cancer. Expert Rev Anticancer Ther. 11:1641-1652.
  • Krell J; James CR; Shah D; Gojis O; Lim A; Riddle P; Ahmad R; Makris A; et alCowdray A; Chow A; Babayev T; Madden P; Leonard R; Cleator S; Palmieri C. (Jun 2011). Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome. CLIN BREAST CANCER. 11:153-160. DOI.
  • Contractor KB; Kenny LM; Stebbing J; Challapalli A; Al-Nahhas A; Palmieri C; Shousha S; Lewis JS; et alHogben K; De Nguyen Q; Coombes RC; Aboagye EO. (Nov 2011). Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. Nucl Med Commun. 32:997-1004. DOI.
  • Krell J; James CR; Shah D; Gojis O; Lim A; Riddle P; Ahmad R; Makris A; et alCowdray A; Chow A; Babayev T; Madden P; Leonard R; Cleator S; Palmieri C. (Jun 2011). Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome. Clin Breast Cancer. 11:153-160. DOI.
  • Palmieri C; Shah D; Krell J; Gojis O; Hogben K; Riddle P; Ahmad R; Tat T; et alFox K; Porter A; Mahmoud S; Kirschke S; Shousha S; Gudi M; Coombes RC; Leonard R; Cleator S. (Apr 2011). Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era. Clin Breast Cancer. 11:93-102. DOI.
  • Stanway SJ; Palmieri C; Stanczyk FZ; Folkerd EJ; Dowsett M; Ward R; Coombes RC; Reed MJ; et alPurohit A. (Apr 2011). Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer. Anticancer Res. 31:1367-1372.
  • Palmieri C; Januszewski A; Stanway S; Coombes RC. (Feb 2011). Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer. Expert Rev Anticancer Ther. 11:179-183. DOI.
  • Palmieri C; Krell J; James CR; Harper-Wynne C; Misra V; Cleator S; Miles D. (Oct 2010). Rechallenging with anthracyclines and taxanes in metastatic breast cancer. Nat Rev Clin Oncol. 7:561-574. DOI.
  • Kenny LM; Contractor KB; Hinz R; Stebbing J; Palmieri C; Jiang J; Shousha S; Al-Nahhas A; et alCoombes RC; Aboagye EO. (15 Aug 2010). Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab. Clin Cancer Res. 16:4236-4245. DOI.
  • Sharma A; Crook T; Thompson A; Palmieri C. (Feb 2010). SURGICAL ONCOLOGY Why biopsying metastatic breast cancer should be routine. NAT REV CLIN ONCOL. 7:71-74. DOI.
  • Gojis O; Rudraraju B; Gudi M; Hogben K; Sousha S; Coombes RC; Cleator S; Palmieri C. (Feb 2010). The role of SRC-3 in human breast cancer. Nat Rev Clin Oncol. 7:83-89. DOI.
  • Kenny LM; Contractor KB; Stebbing J; Ai-Nahhas A; Palmieri C; Shousha S; Coombes RC; Aboagye EO. (1 Nov 2009). Altered Tissue 3 '-Deoxy-3 '-[F-18]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography. CLIN CANCER RES. 15:6649-6657. DOI.
  • Alifrangis C; Harcourt JP; Gojis O; Palmieri C. (12 Sep 2009). Poor reception?. LANCET. 374:948-948.
  • Shousha S; Peston D; Gojis O; Palmieri C. (Sep 2009). An unusual triple-negative breast carcinoma. HISTOPATHOLOGY. 55:364-366. DOI.
  • Gojis O; Rudraraju B; Alifrangis C; Krell J; Libalova P; Palmieri C. (Mar 2010). The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease. Eur J Surg Oncol. 36:224-229. DOI.
  • Contractor KB; Kenny LM; Stebbing J; Al-Nahhas A; Palmieri C; Sinnett D; Lewis JS; Hogben K; et alOsman S; Shousha S; Lowdell C; Coombes RC; Aboagye EO. (1 Sep 2009). [11C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res. 15:5503-5510. DOI.
  • Cleator SJ; Ahamed E; Coombes RC; Palmieri C. (Jun 2009). A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Clin Breast Cancer. 9 Suppl 1:S6-S17. DOI.
  • Francis RE; Myatt SS; Krol J; Hartman J; Peck B; McGovern UB; Wang J; Guest SK; et alFilipovic A; Gojis O; Palmieri C; Peston D; Shousha S; Yu Q; Sicinski P; Coombes RC; Lam EW. (Jul 2009). FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol. 35:57-68.
  • Wang J; Jain S; Coombes CR; Palmieri C. (May 2009). Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience. BREAST J. 15:247-253. DOI.
  • Barrett-Lee PJ; Dixon JM; Farrell C; Jones A; Leonard R; Murray N; Palmieri C; Plummer CJ; et alStanley A; Verrill MW. (May 2009). Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. ANN ONCOL. 20:816-827. DOI.
  • Hiley C; Tutt A; Torres M; Palmieri C. (30 Dec 2008). Adjuvant radiotherapy for breast cancer. BRIT MED J. 337. DOI.
  • Palmieri C; Gojis O; Rudraraju B; Cleator S. (10 Dec 2008). Does ER-beta cx Really Have No Clinical Importance in Tamoxifen-Treated Breast Cancer Patients?. J CLIN ONCOL. 26:5824-5824. DOI.
  • Abbott R; Palmieri C. (Dec 2008). Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. NAT CLIN PRACT ONCOL. 5:727-736. DOI.
  • Cleator SJ; Palmieri C; Coombes CR. (2008). The Ethnic Profile of Triple-Negative Breast Cancer. ONKOLOGIE. 31:580-582. DOI.
  • Stavridi F; Palmieri C. (Dec 2008). Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer. Expert Rev Anticancer Ther. 8:1859-1869. DOI.
  • Slade MJ; Payne R; Riethdorf S; Ward B; Zaidi SA; Stebbing J; Palmieri C; Sinnett HD; et alKulinskaya E; Pitfield T; McCormack RT; Pantel K; Coombes RC. (13 Jan 2009). Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer. 100:160-166. DOI.
  • Neelakantan P; McLean SR; Kenny S; Nathan M; Panchal L; Sandhu G; Coombes CR; Palmieri C. (Jun 2008). Breast cancer metastasizing to the tongue. Can J Surg. 51:E63-E64.
  • Palmieri C; Coombes RC; Kim SB; Cleator S. (19 Jul 2008). Ethnicity and breast cancer research. Lancet. 372:188-189. DOI.
  • Kenny LM; Coombes RC; Oulie I; Contractor KB; Miller M; Spinks TJ; McParland B; Cohen PS; et alHui AM; Palmieri C; Osman S; Glaser M; Turton D; At-Nahhas A; Aboagye EO. (Jun 2008). Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand F-18-AH111585 in breast cancer patients. J NUCL MED. 49:879-886. DOI.
  • McLean SR; Shousha S; Francis N; Lim A; Eccles S; Nathan M; Brock CS; Palmieri C. (Dec 2007). Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. J CUTAN PATHOL. 34:934-938. DOI.
  • Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; et alNewlands ES; Hancock BW; Seckl MJ. (Jul 2007). Management and outcome of healthy women with a persistently elevated beta-hCG. GYNECOL ONCOL. 106:35-43. DOI.
  • Heller W; Mazhar D; Ward R; Sinnett HD; Lowdell C; Phillips R; Shousha S; Fayaz A; et alPalmieri C; Coombes RC. (Jan 2007). Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer. Oncol Rep. 17:253-259.
  • Palmieri C; MacGregor T; Girgis S; Vigushin D. (Dec 2006). Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 59:1334-1336. DOI.
  • Dhillon T; Palmieri C; Sebire NJ; Lindsay I; Newlands ES; Schmid P; Savage PM; Frank J; et alSeckl MJ. (Nov 2006). Value of whole body (18)FDG-PET to identify the active site of gestational trophoblastic neoplasia. JOURNAL OF REPRODUCTIVE MEDICINE. 51:879-887.
  • Palmieri C; Dhillon T; Thirlwell C; Newsom-Davis T; Young AM; Nelson M; Gazzard BG; Bower M. (Jul 2006). Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med. 7:291-293. DOI.
  • Stebbing J; Mazhar D; Lewis R; Palmieri C; Hatzimichael E; Nelson M; Gazzard B; Bower M. (Mar 2006). The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. Ann Oncol. 17:503-506. DOI.
  • Bower M; Palmieri C; Dhillon T. (Feb 2006). AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 19:14-19.
  • Palmieri C; Fisher RA; Sebire NJ; Lindsay I; Smith JR; McCluggage WG; Savage P; Seckl MJ. (20 Aug 2005). Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet. 366:688. DOI.
  • Fraser SP; Diss JK; Chioni AM; Mycielska ME; Pan H; Yamaci RF; Pani F; Siwy Z; et alKrasowska M; Grzywna Z; Brackenbury WJ; Theodorou D; Koyutürk M; Kaya H; Battaloglu E; De Bella MT; Slade MJ; Tolhurst R; Palmieri C; Jiang J; Latchman DS; Coombes RC; Djamgoz MB. (1 Aug 2005). Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res. 11:5381-5389. DOI.
  • Palmieri C; Brock C; Newlands ES. (Jun 2005). Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma. J NEURO-ONCOL. 73:185-185. DOI.
  • Levene AP; Singh G; Palmieri C. (Apr 2005). Therapeutic monoclonal antibodies in oncology. J ROY SOC MED. 98:146-152.
  • Palmieri C; Vigushin D. (24 Mar 2005). Palifermin and chemotherapy-induced oral mucositis. NEW ENGL J MED. 352:1264-1265.
  • Palmieri C; Fisher RA; Sebire NJ; Smith JR; Newlands ES. (Jan 2005). Placental-site trophoblastic tumour: an unusual presentation with bilateral ovarian involvement. Lancet Oncol. 6:59-61. DOI.
  • Palmieri C; Coombes RC; Vigushin DM. (2005). Targeted histone deacetylase inhibition for cancer prevention and therapy. Prog Drug Res. 63:147-181.
  • Palmieri C; Saji S; Sakaguchi H; Cheng G; Sunters A; O'Hare MJ; Warner M; Gustafsson JA; et alCoombes RC; Lam EW. (Aug 2004). The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. J Mol Endocrinol. 33:35-50.
  • Palmieri C; Dhillon T; Coombes C; Vigushin D. (12 Jun 2004). Hypocalcaemia after intravenous bisphosphonate - Adjuvant bisphosphonate is not currently accepted practice. BRIT MED J. 328:1439-1439.
  • Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et alCoombes RC; Bloom SR. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
  • Palmieri C; Vigushin D; Coombes RC. (22 May 2004). Stem-cell therapy for myocardial diseases. LANCET. 363:1734-1735.
  • Palmieri C; Lam EWF; Vigushin D; Coombes RC. (1 May 2004). Value of SERMs in postmenopausal women. LANCET. 363:1477-1478.
  • Palmieri C; Lam EW; Mansi J; MacDonald C; Shousha S; Madden P; Omoto Y; Sunters A; et alWarner M; Gustafsson JA; Coombes RC. (1 Apr 2004). The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival. Clin Cancer Res. 10:2421-2428.
  • Palmieri C; Vigushin DM; Peters TJ. (Mar 2004). Managing malignant disease in patients with porphyria. QJM. 97:115-126.
  • Palmieri C; Barron N; Vigushin DM. (1 Mar 2004). The vincotube system: A design solution to prevent the accidental administration of intrathecal Vinca alkaloids. J CLIN ONCOL. 22:965-965.
  • Palmieri C; Wanaski S; Panse J; Medeiros B. (Jan 2004). The future of clinical cancer research: who's teaching the next generation? The Flims-Vail model. EUR J CANCER. 40:173-175. DOI.
  • Palmieri C; Gillmore R; Menzies-Gow A; Fishpool S; Robinson D; Shaw R; Coombes RC. (Oct 2003). Resolution of late-onset asthma following high-dose chemotherapy. Bone Marrow Transplant. 32:847-848. DOI.
  • Palmieri C; Roberts-Clark D; Assadi-Sabet A; Coope RC; O'Hare M; Sunters A; Hanby A; Slade MJ; et alGomm JJ; Lam EW; Coombes RC. (Apr 2003). Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. J Endocrinol. 177:65-81.
  • Palmieri C; Vigushin D. (13 Jul 2002). Gene-expression profiling and identification of patients at high risk of breast cancer. LANCET. 360:173-173.
  • Palmieri C; Cheng GJ; Saji S; Zelada-Hedman M; Wärri A; Weihua Z; Van Noorden S; Wahlstrom T; et alCoombes RC; Warner M; Gustafsson JA. (Mar 2002). Estrogen receptor beta in breast cancer. Endocr Relat Cancer. 9:1-13.
  • Jensen EV; Cheng GJ; Palmieri C; Saji S; Makela S; Van Noorden S; Wahlstrom T; Warner M; et alCoombes RC; Gustafsson JA. (18 Dec 2001). Estrogen receptors and proliferation markers in primary and recurrent breast cancer. P NATL ACAD SCI USA. 98:15197-15202.
  • Palmieri C; Powles T; Vigushin D. (27 Sep 2001). Trastuzumab and breast cancer. NEW ENGL J MED. 345:996-997.
  • Palmieri C; Saji S; Gustafsson JA; Coombes RC. (9 Sep 2000). False negatives in oestrogen-receptor assay. LANCET. 356:944-944.
  • Palmieri C; Fishpool S. (2 Sep 2000). Breast cancer screening - Screening has to be combined with good surgical and oncological services. BRIT MED J. 321:567-568.
  • Palmieri C. (Sep 2000). Prognostic significance of oestrogen receptor beta in breast cancer. BRIT J SURG. 87:1248-1249.
  • Palmieri C; Fishpool S; Coombes RC. (5 Aug 2000). Tumour markers in malignancies - Two isoforms of oestrogen receptor are now known to exist. BRIT MED J. 321:379-380.
  • Udom DI; Vigushin DM; Linardou H; Graham H; Palmieri C; Coombes RC. (Jan 2000). Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer. Eur J Cancer. 36:177-182.
  • Palmieri C; Linardou H. (21 Aug 1999). Breast cancer in women with palpable breast cysts. LANCET. 354:677-677.
  • Palmieri C. (5 Jun 1999). Trial of prophylactic mastectomy is needed. BRIT MED J. 318:1556-1557.

Conferences

  • Marla S; Cardale J; Dodwell DJ; Skene AI; Gojis O; Abram P; Palmieri C; Cleator SJ; et alBowman A; Doughty JC. HER2 POSITIVE EARLY BREAST CANCERS: WHAT PROPORTION ARE RECEIVING ADJUVANT TRASTUZUMAB THERAPY? A MULTICENTRE AUDIT. 8:14-15. (Sep 2010). DOI.
  • Marla S; Cardale J; Dodwel DJ; Skene AI; Abram P; Palmieri C; Cleator SJ; Gojis O; et alTovey SM; Doughty JC. A multicentre audit of HER2 positive Early Breast Cancers and the reasons why patients do not receive trastuzumab therapy. 8:85-86. (Mar 2010).
  • Kenny LM; Coombes RC; Contractor K; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Lowdell C; et alAboagye E. [11C]Choline-PET imaging of breast cancer. 27. (20 May 2009).
  • Krell J; Harper-Wynne C; Miles D; Misra V; Cleator S; Krell D; Palmieri C. What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data. 27. (20 May 2009).
  • Kenny LM; Contractor K; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Aboagye EO; Coombes RC. Changes in [F-18]Fluorothymidine Pharmacokinetics Following Capecitabine Treatment in Human Breast Cancer Detected by Positron Emission Tomography. 69:765S-765S. (15 Dec 2009).
  • Mclean SR; Shousha S; Francis N; Lim A; Eccles S; Brock CS; Palmieri C. Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. 55:S93-S93. (Jan 2007).
  • Abbott R; Vigushin DM; Coombes RC; Palmieri C. Angiosarcoma of the breast following breast preserving surgery and radiotherapy: A review of the literature. 29th Annual San Antonio Breast Cancer Symposium. 100:S235-S235. (Jan 2006).
  • Seckl M; Dhillon T; Young AM; Mitchell H; Newlands ES; Hancock B; Palmieri C. Management and outcome of healthy women with a persistently elevated serum beta-hCG. 23:475S-475S. (1 Jun 2005).
  • Palmieri C; Macgregor T; Girgis S; Vigushin DM. Serum 25 hydroxyvitamin D levels in early and advanced breast cancer. 23:36S-36S. (1 Jun 2005).
  • Dhillon T; Palmieri C; Newlands E; Franks J; Seckl M. Whole body positron emission tomography (PET) for the detection of residual disease in gestational trophoblastic tumors (GTTs). 23:481S-481S. (1 Jun 2005).
  • Palmieri C; Lam E; Mansi J; Madden P; Warner M; Gustafsson JA; Coombes RC. The expression of ER beta cx in human breast cancer and the relationship to response to endocrine therapy and survival. 82:S62-S62. (2003).
  • Gustafsson JA; Cheng G; Jensen E; Palmieri C; Coombes C; Warner M. The latest on ER-beta in breast cancer. 3rd Biennial International Meeting of the Flemish-Gynaecological-Oncology-Group. 38:S81-S81. (Nov 2002).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook